We help businesses fill their protein needs in a timely and cost efficient manner

A next-generation cell therapy platform unlocking solid tumor indications that current CAR T architectures cannot safely address — beginning with breast cancer and extending across high-unmet-need oncology markets.

Life scientists will contract monoclonal antibodies to targets (glycans, small molecules, etc) essential for R&D to advance clinical and diagnostic programs.

GeneLock places a lock inside engineered cells at the DNA level. This stops biological IP theft by ensuring that nothing is produced without the right chemical passcode.

We at DivineDrive aim to maximize hydration, maximize energy, and minimize the risk of injury due to dehydration through our specialized formula. This formula accomplishes a harmonic union of energy and hydration agents while acting in accordance with NCAA guidelines. The current sports beverage market lacks a product of this nature, creating a high projected demand for DivineDrive. Our priority is the safety of our customers, as well as the overall streamline of benefits our product provides.

Remote Parkinson’s Symptom Tracking

Revolutionize heart health — to save millions of lives from global risk of heart failure through early screening, AI and patient empowerment.

Qualitic holds the IP for a rapid C. difficile bacterial screening device.

User-friendly organoids you can trust

At CerviCare, we're driving an innovation in neck health management with our multi-functional, smart, data-tracking neck brace. While providing robust support to the cervical spine of post-operative patients, our advanced design also helps them manage a healthy lifestyle. We provide an all-in-one cost-effective solution for both healthcare providers and patients to enhance post-operative recovery.